Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vader Nanotechnologies
AddedFeb 19, 2024
UpdatedJun 18, 2026
Vader Nanotechnologies

Vader Nanotechnologies

Seed

Vader Nanotechnologies: Innovating high-throughput screening and optimization of contaminant-consuming strains.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Vader Nanotechnologies specializes in developing innovative high-throughput screening methods for identifying microbial strains capable of consuming specific environmental contaminants. The company focuses on tackling persistent pollutants like PFAS, utilizing a combination of automation, image processing, computer vision, and analytical chemistry. Their proprietary approach aims to discover organisms that can grow solely on difficult-to-break-down chemicals.

The company's technology has significant potential for environmental remediation, particularly in addressing PFAS contamination, which has been detected in a large percentage of the US population. Vader Nanotechnologies further enhances the performance of identified strains through directed evolution techniques, optimizing their ability to break down targeted contaminants. This innovative approach positions the company at the forefront of biotechnology-driven environmental solutions.

Vader Nanotechnologies - Similar Companies

Axnano logo

Axnano

axnano.com

Allied Microbiota logo

Allied Microbiota

Envirobe logo

Envirobe

envirobe.com

OndaVia logo

OndaVia

ondavia.com

Vulcan Biologics logo

Vulcan Biologics

Bluumbio logo

Bluumbio

bluumbio.com

Biota Technology logo

Biota Technology

biota.com

2Witech Solutions logo

2Witech Solutions

Nextbiotics logo

Nextbiotics

next-biotics.com

Arcadia Science logo

Arcadia Science

arcadiascience.com

Terra Bioforge logo

Terra Bioforge

terrabioworks.com

Vivakor logo

Vivakor

vivakor.com

Petri Bio logo

Petri Bio

petribio.com

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Bnnano logo

Bnnano

bnnano.com

Vader Nanotechnologies - Quick Facts

Who are Vader Nanotechnologies' competitors?

Companies similar to Vader Nanotechnologies include Axnano, Allied Microbiota, Envirobe and OndaVia.

When was Vader Nanotechnologies founded?

Vader Nanotechnologies was founded in 2019.

Where is Vader Nanotechnologies' headquarters located?

Vader Nanotechnologies' headquarters is located in New York City, NY, US.

When was Vader Nanotechnologies' last funding round?

Vader Nanotechnologies' most recent funding round was for $525k (USD) in September 2022.

How much has Vader Nanotechnologies raised to-date?

As of Sep 19, 2022, Vader Nanotechnologies has raised a total of $953k (USD).

How many employees does Vader Nanotechnologies have?

Vader Nanotechnologies has 4 employees as of Feb 4, 2024.

Vader Nanotechnologies - Classification

Industry
  • Professional Service Companies
Ownership
  • Venture Capital
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • Americas
Customer
  • Enterprise
  • Government
Main Product
  • Bioremediation
  • Screening
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software